Section IV ยท Last reviewed 2026-05-16
Evaluations and reviews
Systematic reviews, HTA reports and official evaluations that have re-assessed the evidence base of the Dutch Protocol since 2020.
Summary
Since 2020, several official bodies have evaluated the evidence for medical treatment of minors with gender dysphoria. NICE (UK, 2020) rated the evidence for puberty blockers "very low certainty" (source), SBU (Sweden, 2022) found the evidence insufficient (source), and the Cass Review (UK, 2024) found insufficient and/or inconsistent evidence on psychological and psychosocial effects (source). This section provides a summary per evaluation, including COHERE (Finland), Ukom (Norway) and the Florida AHCA review, with the main findings and recommendations.
Subpages
Related
- International comparison โ all countries in one table.
- Per country โ broader context.
- Guidelines international โ primary documents.
- People index โ Cass, Levine, Biggs, Kaltiala.
- Timeline โ evaluations in chronological context.
- FAQ ยท Glossary